Taking the Blood Bank to the Field: The Design and Rationale of the Prehospital Air Medical Plasma (PAMPer) Trial

Abstract Hemorrhage and trauma induced coagulopathy remain major drivers of early preventable mortality in military and civilian trauma. Interest in the use of prehospital plasma in hemorrhaging patients as a primary resuscitation agent has grown recently. Trauma center-based damage control resuscitation using early and aggressive plasma transfusion has consistently demonstrated improved outcomes in hemorrhaging patients. Additionally, plasma has been shown to have several favorable immunomodulatory effects. Preliminary evidence with prehospital plasma transfusion has demonstrated feasibility and improved short-term outcomes. Applying state-of-the-art resuscitation strategies to the civilian prehospital arena is compelling. We describe here the rationale, design, and challenges of the Prehospital Air Medical Plasma (PAMPer) trial. The primary objective is to determine the effect of prehospital plasma transfusion during air medical transport on 30-day mortality in patients at risk for traumatic hemorrhage. This study is a multicenter cluster randomized clinical trial. The trial will enroll trauma patients with profound hypotension (SBP ≤ 70 mmHg) or hypotension (SBP 71–90 mmHg) and tachycardia (HR ≥ 108 bpm) from six level I trauma center air medical transport programs. The trial will also explore the effects of prehospital plasma transfusion on the coagulation and inflammatory response following injury. The trial will be conducted under exception for informed consent for emergency research with an investigational new drug approval from the U.S. Food and Drug Administration utilizing a multipronged community consultation process. It is one of three ongoing Department of Defense-funded trials aimed at expanding our understanding of the optimal therapeutic approaches to coagulopathy in the hemorrhaging trauma patient.

[1]  C. Wade,et al.  Prehospital Transfusion of Plasma and Red Blood Cells in Trauma Patients , 2015, Prehospital emergency care : official journal of the National Association of EMS Physicians and the National Association of State EMS Directors.

[2]  A. Peitzman,et al.  Design of the Study of Tranexamic Acid during Air Medical Prehospital Transport (STAAMP) Trial: Addressing the Knowledge Gaps , 2015, Prehospital emergency care : official journal of the National Association of EMS Physicians and the National Association of State EMS Directors.

[3]  A. Sauaia,et al.  A principal component analysis of postinjury viscoelastic assays: clotting factor depletion versus fibrinolysis. , 2014, Surgery.

[4]  E. Etchill,et al.  State of the art: massive transfusion , 2014, Transfusion medicine.

[5]  B. Spiess.  Prehospital Use of Plasma for Traumatic Hemorrhage , 2014 .

[6]  C. Wade,et al.  Elevated Tissue Plasminogen Activator and Reduced Plasminogen Activator Inhibitor Promote Hyperfibrinolysis in Trauma Patients , 2014, Shock.

[7]  A. Sauaia,et al.  Plasma First in the Field for Postinjury Hemorrhagic Shock , 2014, Shock.

[8]  M. Cohen,et al.  An Update on the Coagulopathy of Trauma , 2014, Shock.

[9]  M. Cohen,et al.  Fibrinogen and platelet contributions to clot formation: Implications for trauma resuscitation and thromboprophylaxis , 2014, The journal of trauma and acute care surgery.

[10]  J. Holcomb,et al.  Optimal trauma resuscitation with plasma as the primary resuscitative fluid: the surgeon's perspective. , 2013, Hematology. American Society of Hematology. Education Program.

[11]  A. Sauaia,et al.  Fibrinolysis greater than 3% is the critical value for initiation of antifibrinolytic therapy , 2013, The journal of trauma and acute care surgery.

[12]  E. Bulger,et al.  Early resuscitation intensity as a surrogate for bleeding severity and early mortality in the PROMMTT study , 2013, The journal of trauma and acute care surgery.

[13]  James G. Chandler,et al.  It's not your grandfather's field plasma. , 2013, Surgery.

[14]  A. Peitzman,et al.  Goal‐directed resuscitation in the prehospital setting: A propensity‐adjusted analysis , 2013, The journal of trauma and acute care surgery.

[15]  R. Tompkins,et al.  Aggressive early crystalloid resuscitation adversely affects outcomes in adult blunt trauma patients: An analysis of the Glue Grant database , 2013, The journal of trauma and acute care surgery.

[16]  E. Bulger,et al.  The prospective, observational, multicenter, major trauma transfusion (PROMMTT) study: comparative effectiveness of a time-varying treatment with competing risks. , 2013, JAMA surgery.

[17]  D. Jenkins,et al.  The development and feasibility of a remote damage control resuscitation prehospital plasma transfusion protocol for warfarin reversal for patients with traumatic brain injury , 2013, Transfusion.

[18]  A. Peitzman,et al.  Characterization of acute coagulopathy and sexual dimorphism after injury: Females and coagulopathy just do not mix , 2012, The journal of trauma and acute care surgery.

[19]  A. Peitzman,et al.  Debunking the survival bias myth: Characterization of mortality during the initial 24 hours for patients requiring massive transfusion , 2012, The journal of trauma and acute care surgery.

[20]  D. Jenkins,et al.  The effects of prehospital plasma on patients with injury: A prehospital plasma resuscitation , 2012, The journal of trauma and acute care surgery.

[21]  M. Cohen,et al.  Characterization of platelet dysfunction after trauma , 2012, The journal of trauma and acute care surgery.

[22]  K. Brohi,et al.  Acute traumatic coagulopathy , 2012, Current opinion in anaesthesiology.

[23]  A. Peitzman,et al.  Crystalloid to packed red blood cell transfusion ratio in the massively transfused patient: When a little goes a long way , 2012, The journal of trauma and acute care surgery.

[24]  A. Blom,et al.  Early Complementopathy After Multiple Injuries in Humans , 2012, Shock.

[25]  R. Lefering,et al.  Hypothermia for Prediction of Death in Severely Injured Blunt Trauma Patients , 2012, Shock.

[26]  C. Silliman,et al.  Proteomic analyses of human plasma: Venus versus Mars , 2012, Transfusion.

[27]  F. Moore.  The use of lactated ringer's in shock resuscitation: the good, the bad and the ugly. , 2011, The Journal of trauma.

[28]  M. Schreiber.  The use of normal saline for resuscitation in trauma. , 2011, The Journal of trauma.

[29]  M. Cohen,et al.  Acute traumatic coagulopathy: from endogenous acute coagulopathy to systemic acquired coagulopathy and back. , 2011, The Journal of trauma.

[30]  A. McDonald,et al.  Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial , 2010, The Lancet.

[31]  A. Sauaia,et al.  VALIDATION OF POSTINJURY MULTIPLE ORGAN FAILURE SCORES , 2009, Shock.

[32]  R. Tompkins,et al.  Inflammation and the host response to injury, a large-scale collaborative project: Patient-oriented research core - Standard operating procedures for clinical care. Foreward , 2008 .

[33]  Kevin Mackway-Jones,et al.  The coagulopathy of trauma: a review of mechanisms. , 2008, The Journal of trauma.

[34]  J. Michalek,et al.  Increased Plasma and Platelet to Red Blood Cell Ratios Improves Outcome in 466 Massively Transfused Civilian Trauma Patients , 2008, Annals of surgery.

[35]  C. Wade,et al.  Increased mortality associated with the early coagulopathy of trauma in combat casualties. , 2008, The Journal of trauma.

[36]  B. Cotton,et al.  Damage control hematology: the impact of a trauma exsanguination protocol on survival and blood product utilization. , 2008, The Journal of trauma.

[37]  C. Wade,et al.  The ratio of blood products transfused affects mortality in patients receiving massive transfusions at a combat support hospital. , 2007, The Journal of trauma.

[38]  M. Cohen,et al.  ROLE OF THE ALTERNATIVE PATHWAY IN THE EARLY COMPLEMENT ACTIVATION FOLLOWING MAJOR TRAUMA , 2007, Shock.

[39]  M. Cohen,et al.  Acute Traumatic Coagulopathy: Initiated by Hypoperfusion: Modulated Through the Protein C Pathway? , 2007, Annals of surgery.

[40]  Michael A Dubick,et al.  Damage control resuscitation: directly addressing the early coagulopathy of trauma. , 2007, The Journal of trauma.

[41]  D. Tweardy,et al.  ESSENTIAL ROLE FOR PLATELETS IN ORGAN INJURY AND INFLAMMATION IN RESUSCITATED HEMORRHAGIC SHOCK , 2006, Shock.

[42]  J. Minei,et al.  Inflammation and the Host Response to Injury, a large-scale collaborative project: patient-oriented research core--standard operating procedures for clinical care. III. Guidelines for shock resuscitation. , 2006, The Journal of trauma.

[43]  Rolf Lefering,et al.  Impact of hemorrhage on trauma outcome: an overview of epidemiology, clinical presentations, and therapeutic considerations. , 2006, The Journal of trauma.

[44]  R. Maier.  Controlling alcohol problems among hospitalized trauma patients. , 2005, The Journal of trauma.

[45]  S. Lowry,et al.  Inflammation and the Host Response to Injury, a large-scale collaborative project: Patient-Oriented Research Core--standard operating procedures for clinical care. I. Guidelines for mechanical ventilation of the trauma patient. , 2005, The Journal of trauma.

[46]  Edward Abraham,et al.  Transfusion-related acute lung injury: definition and review. , 2005, Critical care medicine.

[47]  Mauricio Lynn,et al.  Early coagulopathy predicts mortality in trauma. , 2003, The Journal of trauma.

[48]  M. Lamy,et al.  The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. , 1994, American journal of respiratory and critical care medicine.

[49]  P Hollingsworth-Fridlund,et al.  The epidemiology of traumatic death. A population-based analysis. , 1993, Archives of surgery.

[50]  B. Allaouchiche,et al.  Early coagulopathy in trauma patients: an on-scene and hospital admission study. , 2012, Injury.

[51]  D. Mozingo.  An FFP:PRBC Transfusion Ratio ≥1:1.5 Is Associated With a Lower Risk of Mortality After Massive Transfusion , 2009 .